MedTrace Logo

Stanford Neuromodulation Therapy (SNT) for Non-suicidal Self-injury (NSSI)

NCT06139484 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-11-18

No results posted yet for this study

Summary

To investigate the treatment effect of Stanford Neuromodulation Therapy (SNT) on patients with Non-suicidal Self-injury (NSSI) and the underlying neural mechanism.

Conditions

  • Transcranial Magnetic Stimulation
  • Non-suicidal Self-injury

Interventions

DEVICE

Transcranial Magnetic Stimulation

The stimulations were performed by Magstim RAPID.

Sponsors & Collaborators

  • Anhui Medical University

    lead OTHER

Principal Investigators

  • Yanghua Tian, PhD · Anhui Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2024-08-30
Completion
2024-08-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06139484 on ClinicalTrials.gov